Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002974780 | SCV003280060 | uncertain significance | Muscle AMP deaminase deficiency | 2023-04-26 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 2068373). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with AMPD1-related conditions. This variant is present in population databases (rs775559099, gnomAD 0.007%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 296 of the AMPD1 protein (p.Arg296His). |
Revvity Omics, |
RCV002974780 | SCV003826271 | uncertain significance | Muscle AMP deaminase deficiency | 2019-08-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003377816 | SCV004065725 | uncertain significance | Inborn genetic diseases | 2023-06-21 | criteria provided, single submitter | clinical testing | The c.887G>A (p.R296H) alteration is located in exon 7 (coding exon 7) of the AMPD1 gene. This alteration results from a G to A substitution at nucleotide position 887, causing the arginine (R) at amino acid position 296 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |